Additionally, a lot of nicely founded adverse prognostic markers, like U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their negative influence in patients taken care of with VO. The only component that remained predictive of a shorter development-cost-free survival Within this cohort of clients was TP53 aberrations.112 Ultimately, the